Clinical Trial

OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device

Study acronym: OBPM_PANDA2026
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study, with N = 85 participants minimum over 3 visits spread over 7 days, has been designed to assess the accuracy and precision of the Blood Pressure and pulse rate values as generated by Aktiia.product-G1-US for up to 7 days after initialization in a cohort of subjects representative of the US population.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-03-27; most recent amendment 2026-04-14.
Trial Details
NCT Number NCT07507903
Lead Sponsor Aktiia SA
Conditions Hypertension
Enrollment 200 participants
Start Date 2026-04-20
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-17